[Experimental studies on the optimal administration method of an immunopotentiator in the treatment of malignant tumors--changes in lymphoid tissues and effects on recovery from radiation damage in mice].
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009369:Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000628:therapy*; D011509:Proteoglycans / Q000008:administration & dosage* / Q000494:pharmacology; D011833:Radiation Injuries, Experimental / Q000628:therapy*; D013154:Spleen / Q000187:drug effects* / Q000528:radiation effects
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; C010770:polysaccharide-K